Giuseppina Barsacchi

Dipartimento di Biologia
Università di Pisa
via G. Carducci, 13
56010 Ghezzano (Pisa) - Italia

Peter Burkill 

Marine Institute
Plymouth University
Drake Circus
Plymouth PL4 8AA - United Kingdom

Rita R. Colwell

Center for Bioinformatics and Computational Biology
University of Maryland
296 Biomolecular Sciences Bldg.
Room 3103
College Park, MD 20742 - USA

Roberto Danovaro

Dipartimento Scienze del Mare
Università Politecnica delle Marche
Via Brecce Bianche
60131 Ancona - Italia

Aldo Fasolo

Dipartimento di Biologia Animale e dell’Uomo
Università di Torino
Via Accademia Albertina, 13
10123 Torino - Italia

Bernard Kloareg

Station Biologique Roscoff
Place Georges Teissier - BP74
29682 Roscoff Cedex - France

Noriyuki Satoh

Marine Genomics Unit
Okinawa Institute of Science and Technology
1919-1 Tancha, Onna-son
Kunigami-gun
904-0495 - Japan

Giuseppina Barsacchi

Dipartimento di Biologia
Università di Pisa

Ferdinando Boero 

Dipartimento di Scienze e Tecnologie Biologiche e Ambientali
Università del Salento, Lecce

Gary G. Borisy

Director Marine Biological Laboratory (MBL)
Woods Hole, Mass. Usa

Peter Bukill

Director of the Sir Alister Hardy Foundation for Ocean Sciences and professor of Ocean Science, University of Plymouth, Plymoth, UK

Rita R. Colwell

Professor at University of Maryland College Park and at Johns Hopkins University Bloomberg School of Public Health Environmental Health Sciences, Center for Water and Health
Baltimore, MD, USA

Paul K. Dayton

Integrative Oceanography Division
Scripps Institution of Oceanography
University of California
San Dego, La jolla, CA, USA

Carlos Duarte

Director Instituto Mediterraneo de Estudio Avanzados
Mallorca, Illes Balears, SPAIN

Aldo Fasolo

Dipartimento di Biologia Animale e dell’uomo
Università di Torino

Richard Timothy Hunt – Premio Nobel per la Medicina 2001

London Research Institute, Clare Hall Laboratories
London, UK

Thomas Kiørboe

Professor, Technical University of Denmark
Danish Institute for Fisheries Research
Afd. for Havøkologi og Akvakultur, Kavalergården 6
Charlottenlund, DENMARK

Iain Mattaj

Director General European Molecular Biology Laboratory EMBL
Heidelberg, GERMANY

Christiane Nüsslein-Volhard - Premio Nobel per la Medicina 1995

Director of Dept. of Genetics
Max Planck Institute for Developmental Biology
Tübingen, GERMANY

Noriyuki Satoh

Department of Zoology, Kyoto University
Kyoto, JAPAN

Torsten Wiesel – Premio Nobel per la Medicina 1981

Vincent and Brooke Astor Professor Emeritus and President Emeritus
The Rockefeller University, Laboratory of Neurobiology
New York, NY, USA

Summary

Ocean Medicines is a network of academic, research centres and SMEs across Europe, with proven experience in higher education, training and endowed with state-of-the art scientific and technical expertise and infrastructures. The aim is to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium. To achieve this goal a mobility programme will be set up to prepare a new generation of marine biodiscovery scientists that will be trained on how to isolate compounds from bioactive bacteria/microalgae and take these through to semi-industrial scale-up for further development and toxicity testing at the pre-clinical level. The Ocean Medicines programme also considers commercialization, innovation and entrepreneurship activities including how to start a new business and how to favor an industrial career to seconded researchers. The establishment of this international research network, with its synergistic effects, will significantly contribute to advance all of the involved Institutes/SMEs to the top level in the field of marine drug discovery.

What we do

SZN is involved in WP2 which targets species of bacteria and microalgae that produce bioactive metabolites with anticancer/anti-infective activities; these species will be bulk cultivated under different light/temperature/pH conditions to optimize production of active metobolites. Extracts and fractions will be further screened and chemically analyzed by the other partners.

Partners

SZN, IBP-CNR, SeaLife Pharma, eCoast, Epi-C, UiT, UNIABDN, MEDINA, UWC

Research Area

Marine Biotechnology

SZN role

Partner

Principal Investigator

Adrianna Ianora

Project Manager

Donatella De Pascale

Project lifetime

December 2015 - December 2019

Funding Institutions

European Commission, under the 7th Framework Programme

Personnel involved

Adrianna Ianora, Principal investigator
Giovanna Romano, Experienced researcher

Summary

This project aims to collect samples at the South Shetland Trough (SST) near the Antarctic Peninsula, one of the few cryogenic deep-sea trenches in the world.
The specific aims of PharmaDeep are to:
(a) Collect marine organisms from deep-and-cold-water habitats that may be unique sources of natural products for the treatment of cancer and infectious diseases.
(b) Perform the first marine biological survey of the unique habitat, the SST.
(c) Compare and contrast the SST fauna and drivers of distribution with other trench ecosystems.
(d) Investigate the interaction of physical and chemical extremes of relevance to understanding the habitability of other planetary bodies.

What we do

SZN will be mainly involved in Zooplankton and Phytoplankton sample collection for taxonomy identification, activity screening investigation and later chemical analysis.

Partners

SZN, IBP-CNR, University of Aberdeen, Universitat de Barcelona, Insituto Español de Oceanografía, BioBridge, University of Chile, Nicolaus Copernicus University, Edinburgh University

Research Area

Marine Biotechnology

SZN role

Partner

Principal Investigator

Adrianna Ianora

Project Manager

Alan Jamieson

Project Lifetime

October 2015 - June 2016

Funding Institutions

European Commission, under the EU EUROFLEETS2 program grant agreement n° 312762

Personnel involved

Adrianna Ianora, Principal investigator
Chiara Lauritano, Post-doc
Christian Galasso, PhD Student

Summary

The PharmaSea project focuses on marine biodiscovery research, development and commercialization and brings together a broad interdisciplinary team of academic and industry researchers and specialists to produce new products for development in three accessible market sectors, health (infection, inflammation, CNS diseases), personal care and nutrition. Despite the enormous potential of blue biotechnology, the exploitation of marine natural products, in particular at the commercial scale, has been hindered by a number of constraints. These concern the access of organisms (physical and legal), their genetics, bioactive compound isolation, elucidation of chemical structures and reliable early validation of the biological activity of these compounds. PharmaSea directly aims to overcome some of these bottlenecks leading to improvements in the quality of marine resources available for biotechnological exploitation, to shorten time to market, and develop sustainable modes of supply of raw materials for industry. Within the project a wide variety of marine microorganisms will be analyzed, including collections held by some partners and new collections of strains collected in extreme environmental conditions (deep, hot and cold) in order to isolate new compounds with characteristics appropriate for development by SMEs. The overall objective of PharmaSea is to produce two compounds at large-scale and promote them in pre-clinic evaluations.

What we do

SZN is involved in WP1 and WP2 of this project. SZN objectives are to select and isolate microalgae with potential pharmaceutical activity (e.g. antimitotic, anti-bacterial or for neurodegenerative diseases), and to develop innovative technologies for cell growth in order to increase the production of specific secondary metabolites. Often canonical growth conditions do not allow the activation of specific metabolic pathways. Therefore it is necessary to experiment with new growth conditions in order to obtain a greater concentration of the desired product. Moreover, the aim of the SZN is, also, to scale-up the production of selected strains using 100L photobioreactors  under controlled conditions. Molecular techniques are also being used to identify species and to study the transcriptomes of microalgal strains that show biological activity.

Partners

SZN, Katholieke Universiteit Leuven, The University Court of the University of Aberdeen, MarBio, eCoast, Biodridge, MEDINA, University college Cork, BIOCOM, CNR, Universidade de Santiago de Compostela, The Royal society of chemistry, C-LECTA GMBH, Denmarks Tekniske Universitet, DEEPTEK, Advanced chemistry development UK, Wuhan University, Institute of Microbiology Chinese Academy of Sciences, University of the Western Cape, Instituto de Dinamica Celular y Biotecnologia, Asociacion Instituto Nacional de Biodiversidad, Union Internationale pour la conservation de la nature et de ses ressources, University of Waikato, SeaLifePharma.

Research Area

Marine Biotechnology

SZN role

Partner

Principal Investigator

Adrianna Ianora

Project Manager

Peter de Witte

Project Lifetime

October 2012 - October 2016

Funding Institutions

European Commission, under the 7th Framework Programme (FP7/2007-2013 under grant agreement n° 312184)

Personnel involved

Adrianna Ianora, Principal investigator
Giovanna Romano, Experienced Researcher
Francesco Esposito, Technologist
Chiara Lauritano, Post-doc

PON01_02782 New nanotechnological strategies for the development of drugs and diagnostic tools directed to circulating cancer cells (CTC)

Leader

Biogem S.c.a r.l.

Duration

36 months

Keywords

CTC, antitumor, microalgae

ERC sectors

LS7_3, LS9_9

Summary of the project

The presence of circulating tumor cells (CTC) in the blood is associated with an advanced stage of the disease and reduce survival of cancer patients. Knowledge of the characteristics of the CTC is therefore of fundamental importance for many applications of clinical interest. This project is aimed to isolate CTC from the blood of patients suffering from epithelial and haematological tumors, to develop protocols for the ex-vivo expansion of these cells and to perform a complete molecular characterization in order to clearly define the mutational and transcriptional profiles. This project aims to develop diagnostic kits as well as to identify new molecular targets that may be the target of innovative therapeutic tools for the treatment of these tumors. The project also includes a phase which will identify molecules with anti-tumor activity against CTC, by screening libraries of compounds, substances and natural peptides including natural products arising from innovative sources such as marine microalgae.

Descriptions of activities

The project activities are divided into six objectives (OR).
O.R. 1 Development of nanotechnological devices for the isolation of circulating tumor cells (CTC)
OR2 Molecular characterization of CTC: identification of molecular targets
OR3 Molecular characterization of CTC: development of advanced diagnostic tools
OR4 Development of mouse models for the characterization of CTC
O.R. 5 Development of new technological procedures for targeting and CTC for the optimization of
delivery of drugs and / or molecules with antitumor activity
O.R. 6 Molecular Targeting of CTC
The Zoological Station is involved in the following activities:
Activity 6.2 Identification of molecules of natural and / or synthetic origin with possible biological activity on CTC cells.
The main objective of this activity is to provide extracts and fractions from marine cultivable microalgae with anti-tumor properties, and to isolate and characterize these compounds through a screening system based on biological assays of the fractions obtained from crude extracts. Finally we plan to optimize the production of bioactive compounds of interest through cultivation on a large scale of the producer microorganism(s).

Expected Results

Identification of at least one small molecule with antitumor activity on CTC cells.

Time chart

Tab 1 Costs

Tab 2 Personnel SZN

PON01_00117 Antigens and Adjuvants for Vaccines and Immunotherapy

Leader

Novartis Vaccines & Diagnostics Ltd.

Duration

36 months

Keywords

Biotechnology, human health, microalgae

ERC sectors

LS7_3, LS6_11, LS7_9

Summary of the project

The therapeutic benefits of a stimulation of the innate immune system are well documented. Many substances of natural origin, including some lipidic or glycolipidic molecules are able to stimulate various cellular components of the innate immune system. Therefore metabolites of low molecular weight or lipid components of extracts of marine eukaryotic microorganisms may have activating properties of the innate immune cells and act as adjuvants or immune-modulators.
The innovative approach proposed in this project is based on a public-private partnership and belongs mainly to Areas of Convergence (Sicily, Calabria and Campania).
The project aims to achieve three important goals: 1. The development of innovative vaccines for bacterial and viral infections 2. The development of new molecules with adjuvant action and the study of the mechanism of action of those already known 3. The development of more effective and safe new viral vectors for the development of new vaccines.
The role of the Zoological Station in the project is to identify and cultivate species of marine microalgae that show potential antigen and adjuvant activities.

Descriptinos of the activity

The project involves 3 objectives:
OR 1. Identification of antigenic candidates for the development of potential vaccines against Streptococcus pneumoniae, Clostridium difficile, Escherichia coli pathogens, HCMV
OR 2. Identification of new adjuvants and analysis of the mechanism of action of known adjuvants
OR 3. Identification and validation of new Adenovirus and MVA vectors and Virus Like Particles for use as potential vaccines against infectious diseases (HCMV, Malaria, Influenza, RSV, etc.)
 The Zoological Station participates in activity 2.1
Activity 2.1. Identification of novel natural compounds with immune-modulatory and adjuvant activity from marine microalgae
and in particular in:
RI 2.1.1. Preparation of extracts and fractions from microalgae, isolation and identification of substances with immune-regulatory properties (Stazione Zoologica).
Extracts of marine organisms have already been shown to contain immune-regulatory substances (eg alpha galoctoside ceramide that can stimulate NKT cells) and lipids other than those present in humans. This project aims not only to identify new molecules able to interact with the immune system, but also to identify compounds for therapeutic formulations, for example compounds as adjuvants for vaccines. To this end, the group of dr. Ianora is preparing pellets of microalgae for the isolation and identification of substances with potentially immune-regulatory activity. The fractions are assayed by industrial partners (Novartis) for their ability to activate various cells and receptors of the innate immune system. The study will be performed in collaboration with IBB-CNR (SZN sub-contractor) who will characterize the various active components through the use of NMR techniques.

Time chart

Expected results

To obtain at least one new natural compound from marine microalgae with immuno-stimulatory or adjuvant activity.

Tab 1 Costs

Tab 2 Personnel SZN

PON01_02093 Study of new technologies and technological platforms for the improvement of production processes of active pharmaceutical ingredients of industrial interest and search for new bioactive molecules from natural sources

Leader

Sanofi-Aventis S.p.A.

Duration

36 months

Keywords

natural medicines, chemotherapy, microalgae

ERC sectors

LS7_3, LS9_9

Summary of the project

The overall objective of the project is the study and application of advanced and innovative technologies for the  improvement of productive processes of pharmaceutical industry and the search for new molecules with potential pharmacological activity in the anti-infective, anti- cancer and anti-inflammatory field.
The first research line of the project will study the most innovative aspects of technologies of microbiology and genetics of producer strains.
The second research line will study the possibility to identify new products as candidates of potential pharmaceutical interest in the fields of anti-infectives and more generally in cancer and chronic-degenerative diseases connected with ageing, with particular attention to inflammation role. These activities will be focused on the search for new substances of pharmacological interest by screening extracts from microorganisms and / or aquatic organisms and on the characterization of their beneficial and anti-infection properties.
The project will allow the maintenance of a high scientific and technological concentration of great innovative potential characterized by an organic collaboration between industrial and academic researchers.

Description of activities

The project is divided into two lines, each divided into four development objectives (OR) according to the following scheme:
OR 1.1 - Genetic Improvement / genomic technologies
OR 1.2 - Genetic Improvement / Strain improvement
OR 1.3 - Physiology of fermentation
OR 1.4 - Extraction / Purification
OR 2.1 - New methods for the search of bioactive molecules by microorganisms
OR 2.2 - Summary of chemical derivatives of mature products
OR 2.3 - Identification of target and natural compounds relevant to cancer diseases, and chronic degenerative diseases associated with aging
OR 2.4 - Screening and characterization of extracts from marine organisms
The Zoological Station will be involved in the following activities:
OR 2.4 - Screening and characterization of extracts from marine organisms
The purpose of this Objective is the identification of new active principles with antimicrobial and / or antitumor and / or protective activity against neurodegeneration and / or aging. To achieve this goal the Zoological Station will perform the following activities:
ARI 2.4.1 - Identification of bodies from which to extract the active ingredients and their collection
Will be identified already known that microalgae can be a source of active ingredients with antimicrobial activity, antitumor, antineurodegenerativa, anti-aging. The selection will be made on the basis of their environmental activities.
ARI 2.4.2 - Extraction and sample preparation
Each species of microalgae will be cultivated to SZN so as to obtain a sufficient biomass for the extraction of small molecules by the Institute of CNR of Biomolecular Chemistry (ICB-CNR) as a third party custodial .. Once you have identified the active fractions from the other partners will identify molecule chemistry by the ICB and production in the SZN algae that produce these molecules.

Expected Results

Identification of at least one product that has the characteristics to be evaluated as a new "lead candidate" (New Product).

Time charts

Table 1 Costs

Table 2 Personnel SZN

Project financed in the framework of PON R&C 2007-2013 - PAC Enhancement of public research infrastructures

Coordinator Raffaella Casotti

The project concerns the enhancement of research infrastructures for marine environment located in the Convergence Regions Sicily, Campania and Puglia, where the sea is a primary opportunity of development. The project, called EMSO‐MedIT is the Italian contribution to the consolidation in the above mentioned regions of the European research infrastructure EMSO, which, within the context
of EMSO‐MedIT, is in synergy with the other ESFRI coordinated by Italy (KM3NeT and EMBRC) and the Italian initiative for marine research RITMARE.
 
The actions foreseen will be carried out according to the following objectives:

1) enhancement of marine infrastructures and of scientific and technological facilities to strengthenand expand the network for multidisciplinary monitoring of coastal, deep and the water column
marine environment;

2) networking of all existing and enhanced infrastructures for the transmission in real‐time/near‐realtimeintegrating the data from fixed and relocatable observing systems;

3) establishment of a mobile system of intervention to be used for monitoring campaigns at sites ofstrategic interest or in the case of environmental emergencies.

The network of monitoring infrastructures will be further enhanced through the creation of anexchange information system that will enable the sharing of the large amounts of data, providing access to a large community of Italian and foreign users.

Our role: We are partners of the project and in charge of the WP2 "Strengthening of Campania", together with INGV for the Gulf of Pozzuoli. The expansion includes the acquisition of different oceanographic instrumentation, including a WaveGlider, an ROV, and various sensors, but mainly two buoys type elastic beacon to locate in the Gulf of Naples and Gulf of Pozzuoli for the real-time monitoring and data transmission to the control center of physical and biological environmental data.
Partners: National Institute of Geophysics and Volcanology (INGV), Anton Dohrn Zoological Station (SZN), National Institute of Nuclear Physics (INFN), the National Research Center (CNR), National Institute for Environmental Protection and Research (ISPRA)

IRMA: Implementation and Remote Connection for Real Time Moniotoring of Marine Microorganisms

Funded by the Italian Ministry of University and Education (MIUR)
Scientific Coordinator Raffaella Casotti

This project proposes to use a prototype for the automatic, continuous staining of bacteria for the in situ high frequency monitoring (several times a day, up to every 30 min). This instrument will complement the tools already available to SZN for the monitoring of photosynthetic microorganisms, allowing the definition in close temporal and spatial scale of the microbial compartment. We will study the feasibility of use on sampling boats, even without any technical supervision and, in the long term, on buoys. The data produced will provide useful information on the microbial dynamics at very small time scale in several coastal sites. The final product will be a demonstrator of multiparameter monitoring station that transmits environmental data from different sources in real time, operated remotely, helping to build an early warning system for environmental risk

Our role in the project is to coordinate actions and to test, calibrate and validate the prototype

Partners: SZN, CytoBuoy bv (Holland, George Dubelaar), Eawag (Switzerland, Frederick Hammes), CNRS- MIO (France, Gérald Grégori, Melilotus Thyssen, Michel Denis), INGV (Italian, Giovanni Iannaccone, Sergio Guardato)